Our practitioners only recommend BPC-157 when we believe it will meaningfully support your bodys natural healing processes
When its damaged (a condition called endothelial dysfunction), it becomes sticky, inflamed, and is a primary driver of atherosclerosis, high blood pressure, and other cardiovascular diseases
At the same time, other investigators found some other roles for these polypeptides
However, despite extensive research, the molecular details underlying the interaction of FOXO4 and p53 and the mode of action of FOXO4-DRI remain elusive
Safety Profile: While we wait for PDA human trials, its parent peptide, BPC-157, has shown a great safety profile in early studies with no reported bad side effects on major organs (brain, heart, liver, etc.)
That study helped establish cagrilintide as more than a theoretical amylin analogue